SINTX Technologies

SINTX Technologies

Spinal and orthopedic implant company using its silicon nitride ceramic tech to develop spine and total joint implants. Learn more

Launch date
Employees
Market cap
AUD4.0m
Enterprise valuation
AUD3m (Public information from Sep 2024)
Salt Lake City Utah (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2019202020212022202320242025
Revenues<1m<1m<1m<1m1.2m2.9m3.4m
% growth625 %(14 %)2 %(1 %)104 %132 %20 %
EBITDA(5.6m)(8.6m)(8.8m)(10.0m)(11.5m)(13.4m)(14.5m)
% EBITDA margin(817 %)(1455 %)(1456 %)(1658 %)(942 %)(471 %)(425 %)
Profit(4.8m)(7.0m)(8.8m)(12.0m)(8.3m)(11.8m)(14.1m)
% profit margin(696 %)(1183 %)(1448 %)(2003 %)(674 %)(414 %)(412 %)
EV / revenue5.2x67.5x26.2x8.4x1.3x0.9x0.8x
EV / EBITDA-0.6x-4.6x-1.8x-0.5x-0.1x-0.2x-0.2x
R&D budget3.4m4.8m5.9m6.5m8.7m--
R&D % of revenue493 %809 %971 %1073 %711 %--
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$30.0m

Debt

$21.5m

Debt
N/A

N/A

IPO

$26.0m

Post IPO Debt
*

$13.0m

Post IPO Equity
N/A

$12.7m

Post IPO Equity
N/A

$9.7m

Post IPO Equity
*
N/A

$12.0m

Post IPO Equity
*

$2.0m

Grant
*
N/A

$4.0m

Post IPO Equity
Total FundingAUD81.0m

Recent News about SINTX Technologies

Edit
More about SINTX Technologiesinfo icon
Edit

SINTX Technologies, Inc., based in Salt Lake City, UT, specializes in developing advanced ceramic materials for medical implants. Founded in 1996 by a material scientist and an orthopedic surgeon, the company initially focused on arthroplasty and later expanded into the spine market. SINTX's core product is silicon nitride, a ceramic material known for its strength, durability, and biocompatibility, making it ideal for use in the human body. The company serves medical device manufacturers and healthcare providers, operating primarily in the orthopedic and spine markets. SINTX generates revenue through the sale of its proprietary ceramic materials and licensing its technology to other medical device companies. The business model is centered on innovation, with a strong emphasis on research and development, as evidenced by its portfolio of 12 issued patents and 19 pending patents. SINTX's state-of-the-art manufacturing facility ensures high-quality production standards, further solidifying its position in the market. The company aims to enhance patient outcomes by providing superior implantable materials that reduce the risk of infection and improve the longevity of medical devices.

Keywords: advanced ceramics, medical implants, silicon nitride, orthopedic, spine market, biocompatibility, FDA clearance, proprietary technology, research and development, high-quality manufacturing.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by SINTX Technologies

Edit
Technology Assessment & Transfer
ACQUISITION by SINTX Technologies Jul 2022